Quarterly report [Sections 13 or 15(d)]

Statements of Operations and Comprehensive Loss (Unaudited)

v3.26.3
Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 2,246 $ 2,964 $ 6,642 $ 6,871
General and administrative 6,595 4,378 20,776 15,422
Total operating expenses 8,841 7,342 27,418 22,293
Loss from operations (8,841) (7,342) (27,418) (22,293)
Other income (expenses):        
Interest income 503 279 1,338 661
Interest expense (15) (44)
Change in fair value of warrant liability 1,341 1,067 4,537 9,789
Total other income (expenses) 1,844 1,331 5,875 10,406
Net loss (6,997) (6,011) (21,543) (11,887)
Other comprehensive loss:        
Unrealized loss on marketable securities, net (3) (25)
Net comprehensive loss $ (7,000) $ (6,011) $ (21,568) $ (11,887)
Net loss per share attributable to common stockholders, basic (in Dollars per share) $ (0.25) $ (0.33) $ (0.82) $ (0.85)
Net loss per share attributable to common stockholders, diluted (in Dollars per share) $ (0.25) $ (0.33) $ (0.82) $ (0.85)
Weighted-average shares outstanding used in computing net loss per share 28,270,842 18,065,389 26,381,775 14,038,696
Weighted-average shares outstanding used in computing net loss per share diluted (in Shares) 28,270,842 18,065,389 26,381,775 14,038,696